Skip directly to content

Global aid and emergency relief

Around the world, Pfizer aims to work closely with governments and non-governmental organisations (NGOs) to enable prevention and treatment of disease by making medicines, vaccines and over-the-counter products available to as many people as possible.

Recognising the critical need to provide ongoing aid as well as emergency humanitarian relief, Pfizer Inc. has a three part approach, including medicine donations, cash grants, and other access programmes.

 

Medicine donations

Pfizer believes that medicine donations play an important role in supporting communities around the world. Most of Pfizer’s product donations, which are managed through established NGO partners, are designed to address an expressed need, providing underserved communities with access to potentially life-saving medicines and vaccines.

For example, to support the global strategy towards attempting to eliminate blinding trachoma by the year 2020, Pfizer Inc. has worked with the International Trachoma Initiative (ITI) and the World Health Organization (WHO) since 1998 through our antibiotic donations.1 In 2019, just over 142 million people are at risk of trachoma, a 91% reduction from the 1.5 billion in 2002.2

Here in the UK, we've been supporting the International Health Partners, Europe’s largest coordinator of donated healthcare products, for more than 10 years. Find out more.

 

Cash Grants

In an effort to reach as many people as possible, we support a number of organisations responding to global disasters such as earthquakes, disease outbreaks and humanitarian crises.

In recent years, the Pfizer Foundation* and Pfizer Inc. have provided cash grants to various NGOs providing aid during emergencies such as the refugee crisis in Europe and the Middle East, the Zika outbreak, and Hurricane Matthew in Haiti and the United States.

 

Humanitarian Assistance Programmes

Every day, Pfizer colleagues around the world work collaboratively with governments, non-governmental organizations (NGOs), Civil Service Organizations (CSOs), health care providers (HCPs), and payers to help provide countries with access to our medicines, vaccines and products through our humanitarian assistance programmes.

For example, through a Pfizer Inc. collaboration with Gavi, the Vaccine Alliance, we are helping to broaden access to life-saving vaccinations across 73 of the world's poorest countries.3 Additionally, Pfizer believes that to tackle some of the health challenges faced in low-income countries we must look beyond access to medicines and help to address greater education amongst the health care workers at the forefront of delivering care.

 

*The Pfizer Foundation is a charitable organization established by Pfizer Inc. It is a separate legal entity from Pfizer Inc. with distinct legal restrictions.

 

References

  1. International Trachoma Initiative. Working for a World Free From Trachoma [Online] Last accessed October 2019.
  2. World Health Organisation (WHO). Eliminating trachoma: WHO announces sustained progress with hundreds of millions of people no longer at risk of infection. [Online] Last accessed October 2019.
  3. Pfizer data on file. 
PP-PFE-GBR-2061 / Oct 2019